These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 17123048)

  • 1. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
    Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
    Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
    Gündüz K; Shields CL; Shields JA; Cater J; Brady L
    Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
    Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
    Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.
    Mishra KK; Quivey JM; Daftari IK; Weinberg V; Cole TB; Patel K; Castro JR; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):376-83. PubMed ID: 25841624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma.
    Seregard S; Lundell G; Lax I; af Trampe E; Kock E
    Acta Ophthalmol Scand; 1997 Apr; 75(2):148-54. PubMed ID: 9197561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy.
    Pe'er J; Averbukh E; Frenkel S
    Clin Exp Ophthalmol; 2009 Sep; 37(7):742-3. PubMed ID: 19788674
    [No Abstract]   [Full Text] [Related]  

  • 8. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
    Papageorgiou KI; Cohen VM; Bunce C; Kinsella M; Hungerford JL
    Br J Ophthalmol; 2011 Feb; 95(2):166-70. PubMed ID: 20889528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
    Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
    Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
    Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
    J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plaque radiotherapy for choroidal and ciliochoroidal melanomas with limited nodular extrascleral extension.
    Augsburger JJ; Schneider S; Narayana A; Breneman JC; Aron BS; Barrett WL; Trichopoulos N
    Can J Ophthalmol; 2004 Jun; 39(4):380-7. PubMed ID: 15327103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: a mono-institutional experience.
    Perri P; Fiorica F; D'Angelo S; Lamberti G; Parmeggiani F; Martini A; Carpenteri F; Colosimo C; Micucci M; Perazzini L; De Gugliemo E; Berretta M; Sebastiani A; Cartei F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1919-24. PubMed ID: 23242717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
    Nag S; Quivey JM; Earle JD; Followill D; Fontanesi J; Finger PT;
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):544-55. PubMed ID: 12738332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
    Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
    Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
    Le BHA; Kim JW; Deng H; Rayess N; Jennelle RL; Zhou SY; Astrahan MA; Berry JL
    Brachytherapy; 2018; 17(6):981-989. PubMed ID: 30082188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma.
    Lommatzsch PK; Werschnik C; Schuster E
    Graefes Arch Clin Exp Ophthalmol; 2000 Feb; 238(2):129-37. PubMed ID: 10766281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-onset scleral necrosis after iodine I 125 plaque radiotherapy for ciliochoroidal melanoma.
    Corrêa ZM; Augsburger JJ; Freire J; Eagle RC
    Arch Ophthalmol; 1999 Feb; 117(2):259-61. PubMed ID: 10037576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patients treated between 1980 and 1987.
    Augsburger JJ; Schneider S; Freire J; Brady LW
    Graefes Arch Clin Exp Ophthalmol; 1999 Jul; 237(7):558-67. PubMed ID: 10424306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma.
    Verschueren KM; Creutzberg CL; Schalij-Delfos NE; Ketelaars M; Klijsen FL; Haeseker BI; Ligtenberg SM; Keunen JE; Marijnen CA
    Radiother Oncol; 2010 Jun; 95(3):332-8. PubMed ID: 20416963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.